Look, I get that medicines all have rare side effects. I get that.
But why did our regulator seem completely ignorant on the numbers? They said we had what - 5 cases - and it wasn’t the same issue here. For weeks.
Various EU and non EU countries had already picked up on it - weeks in advance.
We still said we didn’t have the numbers. Then it seems like last week they did more diligence and checked and we found lots more.
So - assuming the MHRA hasn’t deliberately hidden matters which I don’t think they have - then how is our data assessed? If we had 65 cases of this rare clotting issue in various U.K. hospitals shortly after a vaccine, why wasn’t this picked up/recorded/asked/reported? How are doctors and hospitals advised on this?
Why isn’t this being asked in the media? Isn’t this an absolutely massive deal? How can we have trust in the system?
There are now lots of women alleging menstrual changes. A lesser issue perhaps but still a big deal for those TTC or not - what is happening to those cases?
How can I gain trust in the system?